Medtronic says it expects to take a $185 million hit from tariffs in the fiscal year.

Medtronic’s (NYSE: MDT) stock price is amid a textbook reversal, having formed a Head & Shoulders Pattern and broken to fresh highs, confirming the baseline as a critical pivot point. The question now ...

Medtronic (NYSE:MDT) executives used the company’s latest earnings call to highlight accelerating growth in several product ...

On Tuesday, Medtronic disclosed its third-quarter results for fiscal year 2026, reporting a revenue of $9 billion, up 8.7% ...

Medtronic plc MDT reported third-quarter fiscal 2026 adjusted earnings per share (EPS) of $1.36, which fell 2.2% from the ...

Medtronic should see its product cycle move the needle on growth, according to Needham & Co. analysts, who have upped their ...

Medtronic plc ( MDT) is scheduled to announce FQ3 earnings results on Tuesday, February 17th, before market open. The consensus EPS estimate is $1.33 and the consensus revenue estimate is $8.9B. Over ...

Geoff Martha, Medtronic CEO, joins 'Money Movers' to discuss the company's quarterly earnings results, the company's growth ...

Medical device manufacturer Medtronic (NYSE: MDT) is a healthcare industry stalwart. The company, based in the U.S. and Ireland, is one of the largest in its segment, developing and selling a diverse ...

Medtronic's diabetes care unit has grown faster than the rest of its business in recent years. However, the company decided to spin off this segment into a stand-alone corporation. Still, Medtronic ...

Medtronic is separating out its lower-margin diabetes care segment. It's also pouncing on a massive opportunity in robotic-assisted surgery. The healthcare leader has a terrific dividend-growth track ...

A federal jury found that Medtronic, which plans to appeal the ruling, unlawfully monopolized the bipolar surgical device ...